🔎 Trials Near Me

Hjem › Akut myelogen leukemi › Iowa › Cedar Rapids

Kliniske studier for Akut myelogen leukemi i Cedar Rapids, IA

16 studier for Akut myelogen leukemi søker deltakere på steder i og rundt Cedar Rapids (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
  • Mercy Hospital, Cedar Rapids
  • Oncology Associates at Mercy Medical Center, Cedar Rapids
Alder 40 til 75 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05334069

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

RekruttererFase 2
  • University of Iowa/Holden Comprehensive Cancer Center, Iowa City · 25 mi unna
Alder 18 til 59 · Alle kjønn · Oppdatert 28. sep. 2026 · NCT05554393

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

RekruttererFase 2
  • University of Iowa/Holden Comprehensive Cancer Center, Iowa City · 25 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT05564390

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

RekruttererFase 2
  • University of Iowa/Holden Comprehensive Cancer Center, Iowa City · 25 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT06317649

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

RekruttererFase 2
  • University of Iowa/Holden Comprehensive Cancer Center, Iowa City · 25 mi unna
Alder 18 til 59 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT05554406

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

RekruttererFase 3
  • University of Iowa/Holden Comprehensive Cancer Center, Iowa City · 25 mi unna
6 Months – 21 Years · Alle kjønn · Oppdatert 17. sep. 2026 · NCT04293562

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

RekruttererFase 1/2
  • University of Iowa Hospital, Iowa City · 25 mi unna
30 Days · Alle kjønn · Oppdatert 16. sep. 2026 · NCT04065399

A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies

RekruttererObservasjonsstudie
  • University of Iowa Hospital and Clinics, Iowa City · 25 mi unna
Alder 0 og eldre · Alle kjønn · Oppdatert 2. sep. 2026 · NCT07154823

High-dose Ascorbate (HDA) in Combination With Standard of Care Azacitidine and Venetoclax in Acute Myeloid Leukemia (AML)

RekruttererFase 1
  • University of Iowa Health Care, Iowa City · 25 mi unna
Alder 18 til 75 · Alle kjønn · Oppdatert 31. aug. 2026 · NCT07177079

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

RekruttererFase 1/2
  • University of Iowa/Holden Comprehensive Cancer Center, Iowa City · 25 mi unna
Opp til 22 år · Alle kjønn · Oppdatert 25. aug. 2026 · NCT04726241

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

RekruttererFase 3
  • University of Iowa Stead Family Children's Hospital, Iowa City · 25 mi unna
29 Days – 21 Years · Alle kjønn · Oppdatert 24. aug. 2026 · NCT05183035

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

RekruttererFase 3
  • University of Iowa, Iowa City · 25 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 20. aug. 2026 · NCT07007312

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

RekruttererFase 1
  • University of Iowa Hospitals & Clinics, Iowa City · 25 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 20. aug. 2026 · NCT06001788

Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

RekruttererFase 3
  • University of Iowa Hospitals and Clinics, Iowa City · 25 mi unna
Alder 18 til 75 · Alle kjønn · Oppdatert 17. jul. 2026 · NCT05429632

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

RekruttererObservasjonsstudie
  • University of Iowa, Iowa City · 25 mi unna
Alle aldre · Alle kjønn · Oppdatert 6. jul. 2026 · NCT01351545

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

RekruttererFase 1
  • University of Iowa Hospitals & Clinics, Iowa City · 25 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 13. mar. 2026 · NCT05735184

Akut myelogen leukemi-studier i andre byer

Andre studier i Cedar Rapids

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.